Publications by authors named "Alvaro Lopez-Masjuan-Rios"

Background: Cardiac resynchronization therapy (CRT) through permanent His bundle pacing (p-HBP) normalizes interventricular conduction disorders and QRS. Similarly, there are immediate and long-term changes in repolarization, which could be prognostic of a lower risk of sudden death (SD) at follow-up. We aimed to compare the changes in different electrocardiographic (ECG) repolarization parameters related to the risk of SD before and after CRT through p-HBP.

View Article and Find Full Text PDF

Background Or Purpose: His bundle pacing (HBP) is the most physiological form of ventricular pacing. Few prospective studies have analyzed lead localization using imaging techniques and its relationship with electrical parameters and capture patterns. The objective of this study is to examine the correlation between electrical parameters and lead localization using three-dimensional transthoracic echocardiography (3D TTE).

View Article and Find Full Text PDF

Background: NT-proBNP is emerging as a novel tool for improving management of patients with heart failure (HF). The concept of health-related outcomes as the primary endpoint for therapeutic intervention in chronic disease, such as HF, should be the focal point going forward.

Methods: We conducted a prospective real-world study in heart failure with reduced ejection fraction (HFrEF) patients.

View Article and Find Full Text PDF

Background: The association between digoxin and mortality is an unclear issue. In older patients with atrial fibrillation (AF), where use of digoxin is frequent, the evidence of its safety is scarce. Our aim is to assess the safety of digoxin in nonagenarian patients with AF.

View Article and Find Full Text PDF

Background: The prevalence of atrial fibrillation (AF) increases with age. The prescription of anticoagulation in very elderly patients is controversial and sometimes underused. Our objective is to report the incidence and predictors of major bleeding in anticoagulated nonagenarian patients with non valvular atrial fibrillation (NVAF).

View Article and Find Full Text PDF
Article Synopsis
  • A study examined the effects of oral anticoagulation on patients aged 90 and older with atrial fibrillation, finding that this group is often underrepresented in clinical trials.
  • Out of 1,750 nonagenarians analyzed over an average follow-up of nearly 24 months, DOACs showed a lower risk of death and embolic events compared to no anticoagulation, while VKAs did not demonstrate a significant difference.
  • Both DOACs and VKAs were linked to a higher risk of major bleeding, with VKAs also associated with an increased risk of intracranial hemorrhage, highlighting the need for careful management of anticoagulation in this age group.
View Article and Find Full Text PDF